CAMP Continuation Study/Phase 2

CAMP 继续研究/第 2 阶段

• 批准号: 6718049
• 负责人: ROBERT S ZEIGER
• 金额: $ 17.67万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6718049
• 关键词: adolescence (12-20); asthma; body height; child physical development; clinical research; cooperative study; corticosteroids; drug adverse effect; human subject; longitudinal human study; lung development; patient care management; respiratory disorder epidemiology; young adult human (21-34)

The University of California at San Diego (UCSD) and Kaiser Permanente (KP) San Diego have participated as one of the 8 Clinical Centers in the Childhood Asthma Management Program (CAMP) Trial and CAMP Continuation Study (CAMPCS) since contract inception and award in 1991. For CAMP, our site randomized the required 122 children 5-12.years of age with mild to moderate asthma of which 40% were from ethnic minorities. Our research facilities are well equipped and conducive to perform all aspects of CAMPCS/2. The scientific portion of the study is part of the CAMPCS/2 multicenter proposal provided in the Washington University application. We at the UCSD/KP Clinical Center are willing to participate in the additional follow-up requested by this application and our track record as noted above is supportive of our ability to do so.

自合同签订并授予以来，加州大学圣地亚哥分校 (UCSD) 和圣地亚哥凯撒医疗机构 (KP) 作为 8 个临床中心之一参与了儿童哮喘管理计划 (CAMP) 试验和 CAMP 继续研究 (CAMPCS) 1991 年。对于 CAMP，我们的网站随机分配了所需的 122 名 5-12 岁患有轻度至中度哮喘的儿童，其中 40% 来自少数民族。 我们的研究设施设备齐全，有利于开展 CAMPCS/2 的各个方面。该研究的科学部分是华盛顿大学申请中提供的 CAMPCS/2 多中心提案的一部分。我们 UCSD/KP 临床中心愿意参与此申请所要求的额外后续行动，并且我们如上所述的跟踪记录支持我们这样做的能力。